Wasan K M, Ramaswamy M, Cassidy S M, Kazemi M, Strobel F W, Thies R L
Division of Pharmaceutics and Biopharmaceutics, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada.
Antimicrob Agents Chemother. 1997 Sep;41(9):1871-5. doi: 10.1128/AAC.41.9.1871.
The physical characteristics and lipoprotein distribution of free nystatin (NYS) and liposomal NYS (L-NYS) in human plasma were investigated. To determine the percentage of NYS that was lipid associated following incubation in human plasma, C18 reverse-phase extraction columns were used. To assess plasma drug distribution, NYS and L-NYS (20 microg/ml) were incubated in human plasma for 5, 60, and 120 min at 37 degrees C. After each interval, plasma was removed and separated into its lipoprotein and lipoprotein-deficient plasma (LPDP) fractions by ultracentrifugation and assayed for NYS by high-pressure liquid chromatography. Further studies evaluated the liposome structure of L-NYS by filtering through a 0.14-microm-pore-size microfilter before and after the addition of human plasma. When reconstituted L-NYS (mean particle diameter +/- standard deviation, 321 +/- 192 nm) was applied to a C18 column, 67% +/- 4% of the initial NYS concentration was associated with the lipid. When plasma samples containing L-NYS that had been incubated for 5 to 120 min at 37 degrees C were applied to C18 columns, 66 to 76% of the NYS was lipid associated. Incubation of NYS in human plasma for 5 min at 37 degrees C resulted in 3% +/- 1% of the initial NYS concentration incubated in the low-density lipoprotein (LDL) fraction, 23% +/- 4% of that in the high-density lipoprotein (HDL) fraction, and 66% +/- 10% of that in the LPDP fraction. In contrast, the distribution of NYS following incubation of L-NYS in human plasma for 5 min was 13% +/- 2% in the LDL fraction, 44% +/- 5% in the HDL fraction, and 42% +/- 5% in the LPDP fraction. Similar results were observed following 60 and 120 min of incubation. In addition, the liposome structure of L-NYS was quickly lost when mixed with plasma. These findings suggest that rapid disruption of the L-NYS structure upon incubation in human plasma is consistent with its rapid distribution in plasma. The preferential distribution of NYS into the HDL fraction upon incubation of L-NYS may be a function of its phospholipid composition.
研究了游离制霉菌素(NYS)和脂质体制霉菌素(L-NYS)在人血浆中的物理特性和脂蛋白分布。为了确定NYS在人血浆中孵育后与脂质结合的百分比,使用了C18反相萃取柱。为了评估血浆药物分布,将NYS和L-NYS(20微克/毫升)在37℃下于人血浆中孵育5、60和120分钟。在每个时间间隔后,取出血浆,通过超速离心将其分离为脂蛋白和脂蛋白缺乏血浆(LPDP)部分,并通过高压液相色谱法测定NYS。进一步的研究通过在加入人血浆前后通过0.14微米孔径的微滤器过滤来评估L-NYS的脂质体结构。当将重构的L-NYS(平均粒径±标准差,321±192纳米)应用于C18柱时,初始NYS浓度的67%±4%与脂质结合。当将在37℃下孵育5至120分钟的含有L-NYS的血浆样品应用于C18柱时,66%至76%的NYS与脂质结合。NYS在人血浆中于37℃孵育5分钟导致初始NYS浓度的3%±1%存在于低密度脂蛋白(LDL)部分,23%±4%存在于高密度脂蛋白(HDL)部分,66%±10%存在于LPDP部分。相比之下,L-NYS在人血浆中孵育5分钟后NYS的分布为13%±2%在LDL部分,44%±5%在HDL部分,42%±5%在LPDP部分。孵育60和120分钟后观察到类似结果。此外,L-NYS与血浆混合时脂质体结构迅速丧失。这些发现表明,L-NYS在人血浆中孵育时结构的快速破坏与其在血浆中的快速分布一致。L-NYS孵育后NYS优先分布到HDL部分可能与其磷脂组成有关。